S Yedgar Selected Research

PLIalpha

1/2007	A novel treatment of contact dermatitis by topical application of phospholipase A2 inhibitor: a double-blind placebo-controlled pilot study.
9/2003	Amelioration of TNBS-induced colon inflammation in rats by phospholipase A2 inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Yedgar Research Topics

Disease

4	Inflammation (Inflammations) 01/2008 - 04/2002
2	Colitis 09/2003 - 01/2000
2	Myocardial Infarction 03/2002 - 05/2001
1	Hemolysis 12/2011
1	Gaucher Disease (Gaucher's Disease) 01/2008
1	Contact Dermatitis (Eczema, Contact) 01/2007
1	Bronchitis 09/2005
1	Asthma (Bronchial Asthma) 09/2005
1	Hypersensitivity (Allergy) 09/2005
1	Necrosis 09/2005
1	Airway Remodeling 09/2005
1	Hemolytic Anemia 03/2004
1	Thrombosis (Thrombus) 03/2004
1	Infarction (Infarctions) 03/2004
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2003
1	Atherosclerotic Plaque (Atheroma) 07/2002
1	Atherosclerosis 07/2002
1	Neoplasms (Cancer) 07/2002
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2002
1	Schizophrenia (Dementia Praecox) 10/2001
1	Bacterial Infections (Bacterial Infection) 05/2001
1	Unstable Angina 05/2001

Drug/Important Bio-Agent (IBA)

3	Fibrinogen (Factor I)FDA Link 01/2008 - 05/2001
2	PLIalphaIBA 01/2007 - 09/2003
2	LeukotrienesIBA 01/2007 - 09/2005
2	Secretory Phospholipases A2IBA 09/2005 - 07/2002
2	LipidsIBA 09/2005 - 09/2003
2	Phospholipids (Phosphatides)FDA LinkGeneric 09/2005 - 10/2001
1	BuffersIBA 12/2011
1	AlbuminsIBA 12/2011
1	Blood Proteins (Serum Proteins)IBA 01/2008
1	Glucosylceramides (Glucocerebrosides)IBA 01/2008
1	ThromboxanesIBA 01/2007
1	ProstaglandinsIBA 01/2007
1	cysteinyl-leukotrieneIBA 09/2005
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2005
1	OvalbuminIBA 09/2005
1	Phospholipases (Phospholipase)IBA 09/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2005
1	n-butoxyethanol (2-butoxyethanol)IBA 03/2004
1	Peroxidase (Myeloperoxidase)IBA 09/2003
1	Phospholipases A2 (Phospholipase A2)IBA 09/2003
1	phosphatidylethanolamineIBA 09/2003
1	Platelet Activating FactorIBA 09/2003
1	Therapeutic UsesIBA 09/2003
1	Trinitrobenzenesulfonic AcidIBA 09/2003
1	EicosanoidsIBA 09/2003
1	EnzymesIBA 09/2003
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 09/2003
1	LysophospholipidsIBA 09/2003
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2003
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2002
1	EndotoxinsIBA 04/2002
1	fibrin fragment D (D-dimer)IBA 03/2002
1	C-Reactive ProteinIBA 05/2001
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2000
1	Inulin FDA Link 01/2000

Therapy/Procedure

1	Enzyme Replacement Therapy 01/2008
1	Therapeutics 04/2002
1	Thrombolytic Therapy 03/2002
1	Oral Administration 01/2000
1	Rectal Administration 01/2000